-
2 months ago | 
mckinsey.com | Brooke Weddle |Bryan Hancock |Lucy Perez
Leaders have long recognized the importance of a healthy workforce to driving economic productivity. But they might be surprised at the value at stake—and at the size of the employee population in less-than-fine fettle.
-
Jan 21, 2025 | 
mckinsey.com | Anouk Petersen |Lucy Perez |Megan Greenfield |Valentina Sartori
In this annual McKinsey report, we provide a comprehensive, global view of women’s health and explore new opportunities to help close the gap.
-
Jan 9, 2025 | 
mckinsey.com | Guang Yang |Jeff Smith |Lucy Perez |Valentina Sartori
Life sciences is on the cusp of a new era of innovation. The convergence of breakthrough technologies, widespread access to data, and deeper insights into complex biological systems is revolutionizing how the industry approaches R&D. For instance, venture capital funding for machine-learning-enabled drug discovery surged more than sevenfold from 2019 to 2022, according to McKinsey analysis.
-
Jan 9, 2025 | 
mckinsey.com | Brandon Parry |Lucy Perez |Steven Aronowitz
We are in a moment of vast potential in life sciences—of diversified investments, breakthrough discoveries, and rapid expansion of therapeutics into new modalities and platforms. And AI is increasingly enabling data-driven decision-making across the product life cycle, from AI-supported drug candidate selection to real-time clinical trial site monitoring. However, overall industry productivity—whether measured in terms of speed, cost-effectiveness, or ROI—has been stagnant for decades.
-
Dec 16, 2024 | 
mckinsey.com | Alberto Chaia |Lucy Perez |Marukel Nunez Maxwell
Latino-owned small businesses are growing rapidly. Investing in their potential can support future generations of Latino entrepreneurs and boost the US economy.
-
Jul 26, 2024 | 
mckinsey.com | Christof Witte |Lucy Perez |Maria Fernandez |Thomas Weskamp
We look at how decarbonization solutions could help API (active pharmaceutical ingredient) companies reduce their carbon footprint by up to 90 percent.
-
Jun 17, 2024 | 
mckinsey.com | Lucy Perez |Megan Greenfield
At a glance Cardiovascular disease (CVD) is the leading cause of death for women. Cardiovascular conditions in the United States make up at least a third of the women’s health gap because of inequities between women and men in care delivery, efficacy, and data availability. Addressing heart health at every life stage can improve a woman’s quality of life and overall health. It could lead to at least 1.6 million years of higher-quality life and boost the US economy by $28 billion annually by 2040.
-
Mar 19, 2024 | 
thehill.com | Megan Greenfield |Lucy Perez
On Monday, President Joe Biden signed an executive order expanding U.S. government research on women’s health, and announced a $200 million research investment to better understand women’s health issues.
-
Jan 17, 2024 | 
fortune.com | Lucy Perez |Tracy Francis
An analysis of more than 650 research papers found that only half broke down results by sex. Of those that did, women were disadvantaged in some way almost two-thirds of the time. Getty Images
-
Aug 8, 2023 | 
mckinsey.com | Rebecca Doherty |Claudia Kampel |Anna Koivuniemi |Lucy Perez
Consistent and profitable growth has been hard to achieve since the global financial crisis, making it critical for companies to explicitly choose growth in their mindsets, pathways, and execution capabilities. Many executives believe making that growth sustainable and inclusive requires inscrutable trade-offs, forgoing revenue and profit for the sake of society and the planet. That is not always the case.
